首页> 外文OA文献 >Ticagrelor Versus Prasugrel in Acute Coronary Syndrome Patients With High On-Clopidogrel Platelet Reactivity Following Percutaneous Coronary Intervention A Pharmacodynamic Study

【2h】

Ticagrelor Versus Prasugrel in Acute Coronary Syndrome Patients With High On-Clopidogrel Platelet Reactivity Following Percutaneous Coronary Intervention A Pharmacodynamic Study

机译：经皮冠状动脉介入治疗后冠心病血小板反应性高的急性冠脉综合征患者中的替卡格雷与普拉格雷相关性研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Alexopoulos Dimitrios; Galati Anastasia; Xanthopoulou Ioanna; Mavronasiou Eleni; Kassimis George; Theodoropoulos Konstantinos C.; Makris George; Damelou Anastasia; Tsigkas Grigorios; Hahalis George; Davlouros Periklis;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: A pharmacodynamic study [J] . AlexopoulosD., GalatiA., XanthopoulouI., Journal of the American College of Cardiology . 2012,第3期

机译：经皮冠状动脉介入治疗后氯吡格雷血小板反应性高的急性冠脉综合征患者中替卡格雷与普拉格雷的药效学研究
2. Half-dose ticagrelor versus high-dose clopidogrel in reducing platelet reactivity in acute coronary syndrome patients with high on-clopidogrel platelet reactivity (divide study) [J] . Liu Guang Zhong, Zhang Song, Sun Dang Hui, European journal of clinical pharmacology . 2019,第8期

机译：半剂量TiCagreloLOR与高剂量氯吡格雷降低急性冠状动脉综合征患者高氯吡格雷血小板反应性的血小板反应性（划分研究）
3. Differential effect of ticagrelor versus prasugrel on coronary blood flow velocity in patients with non-ST-elevation acute coronary syndrome undergoing percutaneous coronary intervention: An exploratory study [J] . AlexopoulosD., MouliasA., KoutsogiannisN., Circulation. Cardiovascular interventions . 2013,第3期

机译：替格瑞洛与普拉格雷对经皮冠状动脉介入治疗的非ST段抬高急性冠脉综合征患者冠脉血流速度的差异性影响：一项探索性研究
4. Once-daily Nadroparin Versus Twice-daily Nadroparin in the Treatment of Patients with Acute Coronary Syndromes: The SAFRAX Study [C] . V. Hricak, A. Leizorovic International Congress on Thrombosis . 2006

机译：每日一日奈多林与每次每日Nadroparin治疗患者急性冠状动脉综合征患者：Safrax研究
5. The Association between Unfractionated Heparin and Bivalirudin Used during Percutaneous Coronary Intervention for Stable Angina and Acute Coronary Syndromes and the In-Hospital and Mortality Outcomes Observed across All Body Mass Index Groups [D] . Chen, Christine. 2021

机译：在所有体重指数群体中观察到稳定冠状动脉干预期间使用经皮冠状动脉介入和急性冠状动脉综合征的冠状动脉介入和医院和死亡率结果之间的联合肝素和Bivalirudin之间的关联
6. Pharmacodynamic Comparison of Ticagrelor Monotherapy Versus Ticagrelor and Aspirin in Patients After Percutaneous Coronary Intervention: The TEMPLATE (Ticagrelor Monotherapy and Platelet Reactivity) Randomized Controlled Trial [O] . Thomas W. Johnson, Sarah Baos, Laura Collett, 2020

机译：经皮冠状动脉干预后Ticagrelocy对TiCagrelocy对Ticagrelocor和Aspirin的药效表比较：模板（TiCagrelophor Monotherapy和血小板反应性）随机对照试验
7. TICAGRELOR VERSUS PRASUGREL IN ACUTE CORONARY SYNDROME PATIENTS WITH HIGH ON CLOPIDOGREL TREATMENT PLATELET REACTIVITY POST PCI: A PHARMACODYNAMIC STUDY [O] . Alexopoulos Dimitrios, Xanthopoulou Ioanna, Mavronasiou Eleni, 2012

机译：替卡格雷与普拉格雷治疗急性冠脉综合征患者PCI后血小板治疗反应性高：药代动力学研究

Ticagrelor Versus Prasugrel in Acute Coronary Syndrome Patients With High On-Clopidogrel Platelet Reactivity Following Percutaneous Coronary Intervention A Pharmacodynamic Study

著录项

引文网络

相似文献

相关主题

期刊订阅